Shelter Pharma Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing herbal products with a presence in human pharma as well as the veterinary space. It also has a product portfolio of OTC products as well as ethical pharma products. It has OTC and ethical presence in the veterinary segment. Its human health care products include Adalpin-Sp-Tablet, Alkaliser Syrup, B-Kleen Liquid, Baldeepak, Banatone-Syrup, Beta Gulcan, Bipinyl, Chymocure, Cocoment Ointment, Cough Nal, Dia Dys Tablet, D3 Cure, Diabetone Tablet, Emune 19 Capsule, Freshol Hand Cleanser, Happy Forte Capsule, Gynoshel Liquid, and Wormishel Tablet, among others. Its veterinary health care products include Anical Oral, Bijrol Liquid, Biotone Plus Liquid, Bovi Cal-P, Buta-B Bolus, Cal Boost Vet, Calci D Plus, Gasoshel Tablet, Stonyl Tablet, and Sherolax Tablets, among others.As of 25 May 2026, SHELTER PHARMA LIMITED share price is ₹30.63. The stock opened at ₹30.55, compared to its previous close of ₹30.65. During today's trading session, SHELTER PHARMA LIMITED share price moved in the range of ₹30.55 to ₹30.99, with an average price of ₹30.77 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.55 and a high of ₹30.99.
The market capitalization of SHELTER PHARMA LIMITED is ₹52 Crs, with a P/E ratio of 5.8 and a dividend yield of 0.00%.